Stroke

Papers
(The median citation count of Stroke is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association1059
SARS-CoV-2 and Stroke in a New York Healthcare System495
Burden of Stroke in Europe348
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association342
Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions245
Acute Stroke Care Is at Risk in the Era of COVID-19193
Acute Ischemic Stroke and COVID-19191
Thrombectomy for Distal, Medium Vessel Occlusions186
Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke180
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke177
Delays in Stroke Onset to Hospital Arrival Time During COVID-19166
Protected Code Stroke165
Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era161
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities153
Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak147
Acute Stroke in Times of the COVID-19 Pandemic141
Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak140
Review of Perfusion Imaging in Acute Ischemic Stroke133
Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19132
Risk and Secondary Prevention of Stroke Recurrence130
Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic129
Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke119
Break in the Stroke Chain of Survival due to COVID-19118
Challenging the Ischemic Core Concept in Acute Ischemic Stroke Imaging118
Acute Cerebrovascular Events in Hospitalized COVID-19 Patients115
Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19115
Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China109
Decline in Stroke Presentations During COVID-19 Surge108
Machine Learning Approach to Identify Stroke Within 4.5 Hours106
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke103
Cerebrovascular Complications of COVID-19103
Risk Factors for Ischemic Stroke in Younger Adults102
Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis100
Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease100
Impact of Multiple Social Determinants of Health on Incident Stroke96
Tenecteplase Thrombolysis for Acute Ischemic Stroke95
Twenty Years of Progress Toward Understanding the Stroke Belt93
Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study89
Mesenchymal Stromal Cell–Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils88
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams86
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association85
Emergent Large Vessel Occlusion Stroke During New York City’s COVID-19 Outbreak84
Large and Small Cerebral Vessel Involvement in Severe COVID-1984
Urban-Rural Inequities in Acute Stroke Care and In-Hospital Mortality83
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke83
Cancer and Embolic Stroke of Undetermined Source82
Treatment of Spontaneous Subarachnoid Hemorrhage81
Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning78
Trends in Stroke Incidence in High-Income Countries in the 21st Century78
Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI76
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke74
Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic74
Inflammation and Stroke Risk: A New Target for Prevention73
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association71
Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS70
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China70
Low-Frequency Oscillations Are a Biomarker of Injury and Recovery After Stroke70
Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI68
Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment68
Inflammation, Autoimmunity, Infection, and Stroke66
Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment66
Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States66
Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities65
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin65
The Curious Case of the Missing Strokes During the COVID-19 Pandemic64
Cilostazol for Secondary Prevention of Stroke and Cognitive Decline64
Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions64
Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke63
IL (Interleukin)-15 Bridges Astrocyte-Microglia Crosstalk and Exacerbates Brain Injury Following Intracerebral Hemorrhage62
Intravenous Fibrinolysis for Central Retinal Artery Occlusion62
Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Chinese Ischemic Stroke Patients62
Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke62
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis61
Artificial Intelligence Applications in Stroke61
Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis61
Clot-Based Radiomics Predict a Mechanical Thrombectomy Strategy for Successful Recanalization in Acute Ischemic Stroke61
Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword60
Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia60
Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke60
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease59
Comprehensive Stroke Care and Outcomes58
Distinct Commensal Bacterial Signature in the Gut Is Associated With Acute and Long-Term Protection From Ischemic Stroke57
Recommendations for Regional Stroke Destination Plans in Rural, Suburban, and Urban Communities From the Prehospital Stroke System of Care Consensus Conference: A Consensus Statement From the American56
Melbourne Mobile Stroke Unit and Reperfusion Therapy56
Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany56
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events56
Ischemic Stroke Occurs Less Frequently in Patients With COVID-1955
Acute Stroke Presentation, Care, and Outcomes in Community Hospitals in Northern California During the COVID-19 Pandemic55
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study55
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset54
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial54
Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views53
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial53
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy53
Mechanical Thrombectomy in Basilar Artery Occlusion53
Ischemic Stroke Epidemiology During the COVID-19 Pandemic53
Safety and Outcomes of Intravenous Thrombolysis in Posterior Versus Anterior Circulation Stroke52
Endovascular Thrombectomy for Acute Ischemic Strokes52
Qualitative and Quantitative Wall Enhancement on Magnetic Resonance Imaging Is Associated With Symptoms of Unruptured Intracranial Aneurysms51
Acute Cerebrovascular Events With COVID-19 Infection51
Pervasive White Matter Fiber Degeneration in Ischemic Stroke51
Chronic Kidney Disease and Cerebrovascular Disease50
Acute Neurological Deterioration in Large Vessel Occlusions and Mild Symptoms Managed Medically50
Stroke Etiology and Thrombus Computed Tomography Characteristics in Patients With Acute Ischemic Stroke50
Good Clinical Outcome Decreases With Number of Retrieval Attempts in Stroke Thrombectomy49
Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion49
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes49
Mismatch Profile Influences Outcome After Mechanical Thrombectomy48
Endothelial Dysfunction in the Brain48
Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population48
Dynamic Regional Brain Atrophy Rates in the First Year After Ischemic Stroke48
Transforming Growth Factor Beta-Activated Kinase 1–Dependent Microglial and Macrophage Responses Aggravate Long-Term Outcomes After Ischemic Stroke48
Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows48
Higher Doses Improve Walking Recovery During Stroke Inpatient Rehabilitation48
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage47
Brain Atrophy and the Risk of Futile Endovascular Reperfusion in Acute Ischemic Stroke47
PERK (Protein Kinase RNA-Like ER Kinase) Branch of the Unfolded Protein Response Confers Neuroprotection in Ischemic Stroke by Suppressing Protein Synthesis47
Deep Learning–Derived High-Level Neuroimaging Features Predict Clinical Outcomes for Large Vessel Occlusion46
2B, 2C, or 346
Stroke Incidence by Sex Across the Lifespan46
Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use45
SARS-CoV-2 and Stroke Characteristics45
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke45
Bone Marrow Mononuclear Cells Activate Angiogenesis via Gap Junction–Mediated Cell-Cell Interaction45
Computed Tomography Perfusion After Thrombectomy45
Deep Learning Based Software to Identify Large Vessel Occlusion on Noncontrast Computed Tomography44
CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage44
Endovascular Therapy of Anterior Circulation Tandem Occlusions44
Impact of Antiplatelet Therapy During Endovascular Therapy for Tandem Occlusions44
A Nomogram for Predicting Stroke Recurrence Among Young Adults44
Stroke Prognostic Scores and Data-Driven Prediction of Clinical Outcomes After Acute Ischemic Stroke44
High Admission Glucose Is Associated With Poor Outcome After Endovascular Treatment for Ischemic Stroke43
Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack43
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms43
Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset42
Young Women Had More Strokes Than Young Men in a Large, United States Claims Sample42
Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Fa42
Microvascular Dysfunction in Blood-Brain Barrier Disruption and Hypoperfusion Within the Infarct Posttreatment Are Associated With Cerebral Edema42
Placental Mitochondria Therapy for Cerebral Ischemia-Reperfusion Injury in Mice42
Immunodepression, Infections, and Functional Outcome in Ischemic Stroke42
Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke42
Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source42
Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke42
Favorable Venous Outflow Profiles Correlate With Favorable Tissue-Level Collaterals and Clinical Outcome42
Effect of COVID-19 on Emergent Stroke Care42
Large Vessel Occlusion Strokes After the DIRECT-MT and SKIP Trials41
Poststroke Cognitive Impairment Negatively Impacts Activity and Participation Outcomes41
Predicting Infarct Core From Computed Tomography Perfusion in Acute Ischemia With Machine Learning: Lessons From the ISLES Challenge41
Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study41
Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion41
Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation40
Clinical and Imaging Determinants of Collateral Status in Patients With Acute Ischemic Stroke in MR CLEAN Trial and Registry40
Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion40
Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm40
Sleep Duration and Stroke40
Female Stroke40
Acute Stroke Management During the COVID-19 Pandemic40
Mechanical Thrombectomy in Patients With Ischemic Stroke With Prestroke Disability40
Risk of Paradoxical Embolism (RoPE)–Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure40
Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke40
Qualitative Study of Chinese Stroke Caregivers’ Caregiving Experience During the COVID-19 Pandemic39
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation39
Twenty-Year Time Trends in Long-Term Case-Fatality and Recurrence Rates After Ischemic Stroke Stratified by Etiology39
Increased Wall Enhancement During Follow-Up as a Predictor of Subsequent Aneurysmal Growth39
Stroke Acute Management and Outcomes During the COVID-19 Outbreak39
Mobile Stroke Unit Computed Tomography Angiography Substantially Shortens Door-to-Puncture Time39
General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke39
Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke39
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review–Based, Individual Participant Data Network Meta-Analysis39
Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients39
Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown39
Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage39
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection39
Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States39
Recommendations for Clinical Trials in ICH39
Predictors of Poststroke Aphasia Recovery39
Acute Ischemic Stroke in Patients With COVID-1939
Trends of r-tPA (Recombinant Tissue-Type Plasminogen Activator) Treatment and Treatment-Influencing Factors in Acute Ischemic Stroke39
Thrombectomy Versus Combined Thrombolysis and Thrombectomy in Patients With Acute Stroke39
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial39
Association Between the Onset Pattern of Adult Moyamoya Disease and Risk Factors for Stroke38
Advancing Stroke Recovery Through Improved Articulation of Nonpharmacological Intervention Dose38
Endovascular Therapy for Stroke due to Basilar Artery Occlusion38
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage38
Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage38
Embolic Stroke of Undetermined Source and Symptomatic Nonstenotic Carotid Disease38
Thrombectomy in Extensive Stroke May Not Be Beneficial and Is Associated With Increased Risk for Hemorrhage38
Values of Baseline Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score for Treatment Decision of Acute Basilar Artery Occlusion38
Public Health and Cost Benefits of Successful Reperfusion After Thrombectomy for Stroke38
Stroke Care in the United Kingdom During the COVID-19 Pandemic37
Cerebroprotection for Acute Ischemic Stroke: Looking Ahead37
Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease37
Unique Subtype of Microglia in Degenerative Thalamus After Cortical Stroke37
A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent Stroke37
Mechanical Thrombectomy in Medium Vessel Occlusions37
Ischemic Core Overestimation on Computed Tomography Perfusion37
Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia37
Mechanical Characterization of Thrombi Retrieved With Endovascular Thrombectomy in Patients With Acute Ischemic Stroke36
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia36
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association36
Long-Term Cognitive Decline After Stroke: An Individual Participant Data Meta-Analysis35
Lipid-Lowering Therapy and Hemorrhagic Stroke Risk35
Under-Enrollment of Women in Stroke Clinical Trials35
Prediction of Independent Walking in People Who Are Nonambulatory Early After Stroke35
Posterior National Institutes of Health Stroke Scale Improves Prognostic Accuracy in Posterior Circulation Stroke35
Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth35
Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?35
Disentangling Sex Differences in Use of Reperfusion Therapy in Patients With Acute Ischemic Stroke35
Switching to Tenecteplase for Stroke Thrombolysis35
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke35
Sex Differences in Presentation of Stroke: A Systematic Review and Meta-Analysis35
New Insights Into Cerebrovascular Pathophysiology and Hypertension35
Characteristics and Outcomes of Retinal Artery Occlusion34
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke34
Brain Cleanup as a Potential Target for Poststroke Recovery34
Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence34
Predicting Longitudinal Progression in Functional Mobility After Stroke34
Modifiable Risk Factors Associated With Moyamoya Disease34
Neuroinflammation, Stem Cells, and Stroke34
Direct Transfer to Angio-Suite Versus Computed Tomography–Transit in Patients Receiving Mechanical Thrombectomy34
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Trans34
Predictors of Unexplained Early Neurological Deterioration After Endovascular Treatment for Acute Ischemic Stroke34
Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy33
Atrial Fibrillation Following Patent Foramen Ovale Closure33
APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke33
Quantitative Histogram Analysis on Intracranial Atherosclerotic Plaques33
Stenting and Angioplasty in Neurothrombectomy: Matched Analysis of Rescue Intracranial Stenting Versus Failed Thrombectomy33
Early Recanalization With Alteplase in Stroke Because of Large Vessel Occlusion in the ESCAPE Trial33
Bypassing the Closest Stroke Center for Thrombectomy Candidates33
Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn?32
Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients32
Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation32
Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease32
Adherence to the EAT-Lancet Diet and Risk of Stroke and Stroke Subtypes: A Cohort Study32
Adiposity and Outcome After Ischemic Stroke32
Number of Retrieval Attempts Rather Than Procedure Time Is Associated With Risk of Symptomatic Intracranial Hemorrhage32
The Story of Intracerebral Hemorrhage32
Intracranial Atherosclerosis Treatment32
Clinical Course and Mortality of Stroke Patients With Coronavirus Disease 2019 in Wuhan, China32
Detection and Quantification of Symptomatic Atherosclerotic Plaques With High-Resolution Imaging in Cryptogenic Stroke32
Circadian Biology and Stroke32
Determinants of the Presence and Size of Intracranial Aneurysms in the General Population32
Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial32
Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years31
Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment: A HERMES Meta-Analysis31
Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation31
Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS Registry31
Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo31
Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke31
Imaging Markers of Brain Frailty and Outcome in Patients With Acute Ischemic Stroke31
0.029475927352905